Special Medical Liaisons Are No Back Door To Off-Label Promotion - Experts
This article was originally published in The Gray Sheet
Executive Summary
Specialized medical liaisons can help companies navigate scientific discussions on off-label product applications, but are not immune to government enforcement efforts when they cross the line, experts caution
You may also be interested in...
Off-Label Questions, Online: FDA Explains How To Handle Them
FDA draft guidance weighs in on web communications, saying that firms must answer off-label-information questions privately, even if the questions arise in a public online forum.
Stryker Unit Charged With Fraud, Misbranding For Illegal Marketing Scheme
Stryker's biotech division and four former and current executives face charges of wire fraud, conspiracy, device misbranding and false statements related to the marketing of its OP-1 orthopedic bone growth biologic/device combination products
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.